Structure-Based Drug Design for Tuberculosis: Challenges Still Ahead
Structure-Based Drug Design for Tuberculosis: Challenges Still Ahead
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Structure-based and computer-aided drug design approaches are commonly considered to have been successful in the fields of cancer and antiviral drug discovery but not as much for antibacterial drug development. The search for novel anti-tuberculosis agents is indeed an emblematic example of this trend. Although huge efforts, by consortiums and grou...
Alternative Titles
Full title
Structure-Based Drug Design for Tuberculosis: Challenges Still Ahead
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2bbba471a12f4202bc4a15e6d12820a8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2bbba471a12f4202bc4a15e6d12820a8
Other Identifiers
ISSN
2076-3417
E-ISSN
2076-3417
DOI
10.3390/app10124248
